WO2015151693A1 - プレフィルドシリンジ - Google Patents
プレフィルドシリンジ Download PDFInfo
- Publication number
- WO2015151693A1 WO2015151693A1 PCT/JP2015/056188 JP2015056188W WO2015151693A1 WO 2015151693 A1 WO2015151693 A1 WO 2015151693A1 JP 2015056188 W JP2015056188 W JP 2015056188W WO 2015151693 A1 WO2015151693 A1 WO 2015151693A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- syringe barrel
- prefilled syringe
- plunger
- sliding
- outer cylinder
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
- A61M5/3157—Means providing feedback signals when administration is completed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
- A61M2005/3104—Caps for syringes without needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
- A61M2005/3139—Finger grips not integrally formed with the syringe barrel, e.g. using adapter with finger grips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/50—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
- A61M5/5013—Means for blocking the piston or the fluid passageway to prevent illegal refilling of a syringe
- A61M5/502—Means for blocking the piston or the fluid passageway to prevent illegal refilling of a syringe for blocking the piston
- A61M2005/5033—Means for blocking the piston or the fluid passageway to prevent illegal refilling of a syringe for blocking the piston by use of an intermediate blocking member positioned between the syringe barrel and the piston rod to prevent retraction of the latter, e.g. toothed clip placed on the piston rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/586—Ergonomic details therefor, e.g. specific ergonomics for left or right-handed users
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
Definitions
- the present invention relates to a prefilled syringe in which a drug solution is preliminarily stored in a syringe barrel, and allows a user to detect the completion of discharge of the drug solution.
- the drug solution is administered to a recipient such as a patient using a prefilled syringe in which the drug solution is stored in advance.
- the prefilled syringe has a syringe barrel containing a chemical solution.
- a gasket that is hermetically sealed so as not to leak the drug solution and a plunger that slides the gasket are inserted into the syringe barrel.
- Patent Document 1 discloses a syringe barrel having a drug solution discharge portion with a reduced diameter at the tip, a syringe needle connected to the drug solution discharge portion, a gasket slidably housed in the syringe barrel, The plunger attached to the base end surface, the chemical liquid contained between the gasket and the chemical liquid discharge part in the syringe barrel, the outer cylinder in which the syringe barrel and the plunger are inserted, and the distal end portion of the outer cylinder are slidable
- a prefilled syringe having a cylindrical living body abutting member that is fitted to the housing and accommodates an injection needle, and a coil spring that urges the living body abutting portion toward the tip within the outer cylinder.
- the coil spring when the living body contact portion is pressed against the surface of the living body, the coil spring is compressed and the living body contact portion slides in the outer cylinder, and the protruding and retracted injection needle is a living body surface such as skin.
- the coil spring expands and the injection needle is accommodated again in the living body contact portion.
- a vaccine such as an influenza vaccine can induce immunity effectively in a small amount by administering it intradermally as compared with the case of administering subcutaneously.
- intradermal is a hard tissue compared to subcutaneous, high pressure is required even in a small amount for intradermal administration. For this reason, in the prefilled syringe for intradermal administration for intradermal administration, the plunger must be pushed with a higher pressing force than the prefilled syringe for subcutaneous administration.
- Admins such as a doctor who administers a drug solution into the recipient's skin could not clearly detect the response to the completion of discharge caused by the gasket hitting the tip of the inner wall of the syringe barrel due to the high pressing force. Therefore, even though all of the liquid medicine has been drained, the administrator continues to push the plunger, resulting in the burden of the operator needlessly pressing the plunger with a pressing force that exceeds that at the time of administration. It was. This has led to an increase in the workload of doctors who are the administrators, especially when the drug solution is continuously administered to many recipients, such as inoculation of vaccines. In addition, there was anxiety as to whether or not all drug solutions were reliably administered to the recipient.
- Such a problem may also occur in a prefilled syringe that administers a high-concentration chemical solution with a thin inner and outer diameter injection needle in order to reduce the pain felt by the recipient when the needle is punctured and when the chemical solution is administered.
- Biopharmaceuticals such as insulin tend to increase the viscosity of the drug solution as the concentration of the drug solution increases. Therefore, prefilled syringes that administer high-concentration biologics with a thin injection needle can also be used as normal prefilled syringes for subcutaneous administration. In comparison, the plunger must be pressed with a high pressing force.
- Prefilled syringes can be administered easily and quickly even when the plunger is pressed at the time of drug administration by administering a drug solution such as a vaccine intradermally or by administering a high concentration drug solution with a thin needle.
- a drug solution such as a vaccine intradermally or by administering a high concentration drug solution with a thin needle.
- the present invention has been made to solve the above-described problem. Even when the plunger pressing force is high at the time of administration of the chemical solution, the user can easily, quickly and reliably confirm that the drug solution is almost completely discharged. It is an object of the present invention to provide a prefilled syringe that can be sensed.
- the prefilled syringe of the present invention made to achieve the above object includes a syringe barrel provided with a drug solution discharge portion at the tip and an opening at the base end, and the drug solution discharge portion detachably attached to the syringe barrel.
- a cap inserted into the syringe barrel, a shaft portion inserted into the syringe barrel from the opening, and provided at the proximal end of the shaft portion and pressed by a human hand.
- a plunger that slides the gasket toward the drug solution discharge part by moving in the distal direction by a pressing operation to the press part, and the drug solution discharge part and the gasket in the syringe barrel.
- the height of the stepped portion is preferably at least 0.5 mm.
- the difference between the movement distance M of the plunger until the oscillating portion gets over the raised portion and the sliding distance L of the gasket until the discharge of the chemical solution is ⁇ 3.0 mm ⁇ LM ⁇ ⁇ It may be 3.0 mm.
- the oscillating portion protrudes from a side surface of the shaft portion and has a flexible portion having an inclined portion that is inclined outward with respect to a central axis of the shaft portion in a natural state; It is preferable to have a sliding part that is connected to the part and slides on the raised part.
- the sliding portion may have a sliding portion side step portion that is substantially perpendicular to the central axis of the shaft portion at the base end.
- the flexible portion is branched from the side surface of the shaft portion on the distal end side with respect to the sliding portion, protrudes toward the sliding portion, and includes the inclined portion. It is preferable to have.
- the prefilled syringe is branched from the side surface of the shaft portion proximal to the position where the distal end side flexible portion is branched from the side surface of the shaft portion, and is connected to the sliding portion and includes the inclined portion. It is preferable that the flexible portion further includes a proximal-side flexible portion.
- the base end side flexible portion may branch out from the side surface of the shaft portion on the base end side with respect to the sliding portion.
- the prefilled syringe has a plurality of curved and / or bent arch portions between the one end connected to the side surface of the shaft portion and the other end connected to the sliding portion. It is preferable that at least a part of the arch portion includes the inclined portion.
- the prefilled syringe has a first arch portion in which the arch portion warps in a convex shape with respect to the side surface of the shaft portion on the one end side, and a second arch in which the other end side warps in the opposite direction to the first arch portion. It is preferable to have a part.
- the prefilled syringe is branched from the side surface of the shaft portion on the distal end side with respect to the sliding portion, extends toward the sliding portion, includes a distal end-side flexible portion including the inclined portion, and the sliding portion
- the flexible portion has a proximal-side flexible portion that branches off and protrudes from the side surface of the shaft portion closer to the proximal end and is connected to the sliding portion while having the arch portion. May be.
- the proximal end side flexible portion is connected to the side surface of the shaft portion on the proximal end side with respect to the sliding portion.
- the prefilled syringe includes a branch portion branched from a side surface of the shaft portion in a direction perpendicular to the central axis of the shaft portion, and a proximal direction extending from the branch portion in the proximal direction to the sliding portion.
- the distal end side flexible portion may have the inclined portion in which the distance from the side surface of the shaft portion becomes gradually longer as it goes to.
- the prefilled syringe has a sliding portion inclined surface in which the distance between the sliding portion and the side surface of the shaft portion is gradually shortened toward the tip of the shaft portion.
- the prefilled syringe may have a sliding portion inclined surface in which the distance between the raised portion and the central axis of the syringe barrel becomes gradually shorter toward the tip of the syringe barrel.
- the prefilled syringe has a flange portion that protrudes from the side surface of the shaft portion and abuts against the inner wall surface of the syringe barrel to suppress the inclination of the plunger with respect to the central axis of the syringe barrel. Is preferred.
- At least one flange portion is provided on the distal end side and the proximal end side with respect to the oscillation portion.
- the prefilled syringe has a syringe barrel main body in which the gasket is inserted, and at least a part of the prefilled syringe from the periphery of the insertion port portion to the proximal end side.
- the opening is provided at the proximal end, the inner diameter larger than the inner diameter of the syringe barrel body from the periphery of the insertion opening to the opening, and the bulge provided on the proximal side from the insertion opening
- the syringe barrel includes an outer cylinder having a portion, and the height of the stepped portion is smaller than half the difference between the inner diameter of the outer cylinder and the inner diameter of the syringe barrel body.
- a guide rib or a guide groove formed in a line along the central axis of the outer cylinder is formed on the inner wall surface of the outer cylinder, and the guide rib or the guide is formed on the shaft portion of the plunger. It is preferable that a guide engaging portion that guides the oscillation portion to the raised portion while preventing the plunger from rotating by engaging with the groove is provided.
- the prefilled syringe has an engaging protrusion protruding from the shaft portion between the portion where the plunger is inserted into the syringe barrel main body of the shaft portion and the oscillating portion, and the plunger extends from the opening portion.
- the engagement protrusion may get over the raised portion and engage with the stepped portion, thereby preventing reuse.
- the prefilled syringe includes the syringe barrel main body having the syringe barrel flange protruding from the peripheral edge of the insertion port portion, and the outer cylinder into which the syringe barrel main body is inserted.
- the injection having a support protrusion protruding from the inner wall surface of the outer cylinder and supporting the distal end surface of the syringe barrel flange, and a claw protruding from the inner wall surface of the outer cylinder at a position different from the raised portion in the circumferential direction. It is preferable that the cylindrical flange is sandwiched and locked between the support protrusion and the claw.
- the plunger In the prefilled syringe, the plunger is not fixed to the gasket, and the gasket is slid toward the chemical solution discharge portion by bringing the distal end of the plunger into contact with the proximal end of the gasket.
- the oscillating portion may prevent the plunger from returning to the original position by engaging with the stepped portion after getting over the raised portion.
- the prefilled syringe is preferably used to administer the drug solution into the skin.
- the oscillating part is repelled almost simultaneously with the completion of the discharge of the chemical solution and generates a click sound and a click vibration.
- the step part is formed almost perpendicular to the central axis of the syringe barrel at the tip of the bulge part, when the oscillating part gets over the bulge part, it is surely repelled to generate click sound and click vibration Can do.
- the sliding portion side step portion of the oscillating portion slides on the raised portion and bends inward substantially perpendicular to the central axis of the syringe barrel, so that the central axis of the plunger shaft portion during administration is the center axis of the syringe barrel. Even when it deviates from the central axis, the timing at which the click sound or click feeling is almost unchanged does not change, so that the administra- tor can always sense it almost simultaneously with the completion of the discharge of the drug solution.
- FIG. 4B is a cross-sectional view taken along the line AA in the side view of FIG. 4A showing the form of the prefilled syringe of the present invention.
- FIG. 4B is a cross-sectional view taken along the line BB in the side view of FIG. 4A showing the form of the prefilled syringe of the present invention.
- FIG. 4b is a partial enlarged cross-sectional view taken along arrow DD in the side view of FIG. 4a showing the form of the prefilled syringe of the present invention.
- It is a partial side view which shows another example of the oscillation plate used for the prefilled syringe of this invention.
- FIG. 9B is a partial cross-sectional view taken along the line BB in the side view of FIG. 9A showing the form of the prefilled syringe of the present invention.
- FIG. 1 shows a partially cutaway perspective view of one embodiment of the prefilled syringe 1 of the present invention.
- the prefilled syringe 1 has a syringe barrel 10 and a plunger 50.
- the syringe barrel 10 includes an outer barrel 30 and a transparent syringe barrel body 40 that is inserted into the outer barrel 30 and contains the drug solution 100.
- Most of the plunger 50 is inserted into the syringe barrel 10.
- the outer cylinder 30, the syringe barrel main body 40, and the plunger 50 are located on the same axis.
- the outer cylinder 30 is a cylinder whose both ends are open, and has an inner diameter larger than the inner diameter of the syringe barrel main body 40.
- the raised portion 36 is formed by a raised portion side inclined surface 36c whose distance from the central axis of the outer cylinder 30 is gradually shortened toward the tube tip 31 of the outer cylinder 30, a stepped portion 36a that is substantially vertical, and a sharp peak. And a certain top 36b.
- the raised portion-side inclined surface 36c is slightly curved so that the gradient becomes tighter toward the top 36b (see FIG. 2A).
- the stepped portion 36a only needs to have a step substantially perpendicular to the central axis of the outer cylinder 30 from the top 36b, which is the inward apex, toward the inner wall surface of the outer cylinder 30. That is, the surface facing the tip of the stepped portion 36a is not a surface substantially perpendicular to the central axis of the outer cylinder 30, but may be inclined from the top 36b in the proximal direction.
- the outer cylinder 30 has an annular protrusion 37 (see FIG. 2A) whose outer diameter and inner diameter are larger than that of the cylinder tip 31 in the vicinity of the opening 39, and an outer peripheral surface of the outer cylinder 30 that is continuous therewith. It has a hook-shaped finger hook portion 37b protruding outward.
- the elongated plunger 50 includes a shaft portion 51 having a cross-shaped cross section, an oscillating portion 60 protruding from a side surface of the shaft portion 51, and the oscillating portion 60 sandwiched between the distal end side and the proximal end side thereof.
- the flanges 52 and 53 projecting in the direction perpendicular to the central axis of the shaft 51 and the disc having a smaller diameter than the opening 39 of the outer cylinder 30 are pressed against the cylinder tip 31 by pressing the plunger 50.
- a pressing portion 54 to be moved.
- the plunger 50 is made of resin.
- the shaft part 51, the flange parts 52 and 53, the pressing part 54, and the oscillation part 60 are integrally molded.
- An elastic gasket 43 that is in liquid-tight contact with the inner wall of the syringe barrel body 40 is in contact with the distal end side of the plunger 50 so as to be slidable in the syringe barrel body 40.
- the distal end side of the shaft portion 51 is inserted into the syringe barrel main body 40.
- the oscillating portion 60 branches from the side surface of the shaft portion 51 and protrudes, and in a natural state, the oscillating portion 60 is connected to the flexible portion 60a and a flexible portion 60a having an inclined portion inclined outward with respect to the central axis of the shaft portion 51. It is a thin plate comprising a sliding portion 60b that slides on the raised portion 36 of the outer cylinder 30.
- the flexible portion 60a includes a distal-end-side flexible portion 61 branched from the side surface of the shaft portion 51 on the distal end side from the sliding portion 60b, and a base branched from the side surface of the shaft portion 51 on the proximal end side relative to the sliding portion 60b. And an end-side flexible portion 62.
- the distal end side flexible portion 61 branches from the shaft portion 51 in a direction perpendicular to the central axis thereof, and protrudes from the branch portion 61a and extends toward the pressing portion 54 and slides. And a distal end side inclined portion 61b connected to the portion 60b.
- the tip side inclined portion 61b is inclined so that the distance from the side surface of the shaft portion 51 gradually decreases as it goes from the sliding portion 60b to the branch portion 61a.
- the proximal-side flexible portion 62 includes a connecting portion 62b that branches from the side surface of the shaft portion 51 in a direction perpendicular to the central axis thereof, and an arch portion that protrudes from the connecting portion 62b and is connected to the sliding portion 60b.
- the arch portion 62a is composed of a first arch portion that is convexly curved with respect to the side surface of the shaft portion 51, and a second arch portion that is curved in a direction opposite to the first arch portion.
- One end of the first arch portion is connected to the connection portion 62b, and the other end thereof is connected to one end of the second arch portion.
- the other end of the second arch portion is connected to the sliding portion 60b.
- a part of the arch portion 62a corresponds to the inclined portion described above. That is, the inclined portion of the flexible portion 60a is composed of the tip-side inclined portion 61b and a part of the arch portion 62a.
- the sliding portion 60b is continuously connected to the tip-side inclined portion 61b and slides on the protruding portion-side inclined surface 36c.
- the sliding portion-side inclined surface 63b has a shaft at the base end of the sliding portion-side inclined surface 63b.
- the slide part side step part 63a which is a surface perpendicular to the central axis of the part 51 is provided.
- the oscillation part 60 is rich in flexibility by being a thin plate made of resin and having the two flexible parts 61 and 62.
- the sliding part side step part 63a should just form the level
- the chemical solution 100 is sandwiched and accommodated between the gasket 43 and the chemical solution discharge portion 41 (see FIG. 2A) whose diameter is smaller than that of the barrel portion 44 in the interior of the barrel portion 44.
- a cap 21 for sealing the drug solution discharge portion 41 is detachably attached to a luer lock adapter 42 provided at the tip of the syringe barrel main body 40 by screwing.
- the gasket 43 is slid toward the chemical solution discharge part 41 when the plunger 50 moves toward the cylinder tip 31 by a pressing operation by a human hand to the pressing part 54. Thereby, the chemical solution 100 is discharged from the chemical solution discharge portion 41.
- the plunger 50 is not fixed to the gasket 43. When the plunger 50 moves toward the cylinder tip 31, the plunger 43 is discharged from the chemical solution by bringing the tip of the plunger 50 into contact with the base end of the gasket 43. Slide toward part 41.
- FIG. 2 is a partial cross-sectional view showing the prefilled syringe 1 during use.
- FIG. 2A shows a state immediately before the prefilled syringe 1 is used and before the chemical solution 100 is discharged.
- a hub 23 having an injection needle 22 for administering the drug solution 100 into the skin is screwed onto the luer lock adapter 42 while covering the drug solution discharge portion 41.
- the injection needle 22 passes through the hub 23 and communicates with the inner space of the drug solution discharge portion 41.
- the pressing portion 54 and the identification portion 51 a between the pressing portion 54 and the flange portion 53 protrude from the opening 39.
- the two raised portions 36 protrude at positions facing each other across the central axis of the outer cylinder 30.
- the sliding distance L by which the gasket 43 slides until the discharge of the chemical solution 100 is completed, and the distance from the sliding portion side step portion 63a of the oscillating portion 60 to the top 36b of the raised portion 36, that is, the oscillating portion 60 is raised.
- the moving distance M by which the plunger 50 moves before getting over is substantially equal. As a result, the oscillating portion 60 gets over the raised portion 36 almost at the same time when the gasket 43 reaches the tip of the barrel portion 44 and the discharge of the chemical solution 100 is completed.
- FIG. 2 (b) shows the prefilled syringe 1 while the chemical solution 100 is being discharged.
- This figure shows a state in which the pressing portion 54 is pressed and the drug solution 100 is discharged from the injection needle 22.
- the oscillating portion 60 rides on the raised portion 36 by the sliding portion side inclined surface 63b of the sliding portion 60b sliding on the raised portion side inclined surface 36c of the raised portion 36.
- the distal end side inclined portion 61b of the distal end side flexible portion 61 is slightly bent into an S shape with the branch portion 61a and the top 36b as fulcrums.
- the arch portion 62a of the proximal end side flexible portion 62 is bent so that the first arch portion and the second arch portion are more curved.
- the oscillating unit 60 can accumulate large stress as a whole because the flexible unit 60a includes the two flexible units 61 and 62 that are sufficiently bent.
- the oscillating portion 60 has a flexible portion 60a including an inclined portion that is inclined outward with respect to the central axis of the shaft portion 51 in a natural state. For this reason, when the flexible portion 60 a is bent, the sliding portion 60 b is displaced inward in a substantially vertical direction with respect to the central axis of the shaft portion 51. Further, the flexible portion 60a branches off from the side surface of the shaft portion 51 at the distal end side with respect to the sliding portion 60b, and the distal end side flexible portion 61 including the inclined portion described above and the proximal end side with respect to the sliding portion 60b. It has a proximal end side flexible portion 62 that branches off from the side surface of the shaft portion 51 and includes the aforementioned inclined portion.
- the proximal-side flexible portion 62 is bent so that the first arch portion and the second arch portion are more curved. For this reason, since the stress at the time of bending of the base end side flexible part 62 is dispersed without concentrating on one place, the stress accumulated in the oscillating part 60 hardly remains as distortion. As a result, when the oscillating unit 60 gets over the raised portion 36, the stress accumulated in the oscillating unit 60 is more reliably released, and the oscillating unit 60 is reliably repelled and vibrates.
- the bulged portion side inclined surface 36c is slightly curved so that the gradient becomes tighter toward the top 36b, the stress is rapidly increased as the sliding portion 60b approaches the top 36b by the pressing of the pressing portion 54. Due to this stress, the sliding portion 60b is biased toward the raised portion-side inclined surface 36c, so that a frictional resistance is generated between the sliding portion 60b and the raised portion-side inclined surface 36c.
- FIG. 2 (c) shows the prefilled syringe 1 after the chemical solution 100 is discharged.
- the figure shows a state in which the plunger 50 is pushed out and the gasket 43 reaches the tip of the body portion 44. Almost simultaneously with this arrival, the sliding portion 60b gets over the top 36b, and the stress accumulated in the oscillating portion 60 is released at once from the acute top 36b. As a result, the oscillation unit 60 is bounced and vibrates, and a clicking sound and a clicking vibration are generated simultaneously.
- the administrator can recognize that the discharge of the drug solution 100 is completed by listening to the click sound or sensing the click vibration. Moreover, the click sound and the click vibration cause the human to feel that the desired operation has been completed. Therefore, the prefilled syringe 1 gives the administrator a sense of security that the drug solution 100 has been reliably administered to the recipient. Can be given.
- the sliding distance L of the gasket 43 and the moving distance M of the plunger 50 it is difficult to match the sliding distance L of the gasket 43 and the moving distance M of the plunger 50 in all the prefilled syringes 1, so that the range of ⁇ 3.0 mm ⁇ LM ⁇ 3.0 mm It is preferable to set by.
- the administrator applies a force to push the pressing portion 54 of the plunger 50 and holds it for several seconds after detecting the click sound or the click vibration.
- the prescribed amount of the drug solution 100 can be reliably administered to the recipient in all the prefilled syringes 1.
- the oscillating unit 60 gets over the raised portion 36 and the click sound and the click vibration are generated even though the discharge of the chemical solution 100 is completed.
- the pressing portion 54 is unnecessarily kept pressed with a higher pressing force than when the chemical solution 100 is discharged. For this reason, the work burden of the administration person increases.
- the sliding distance L and the moving distance M are preferably set in the range of ⁇ 2.5 mm ⁇ LM ⁇ 2.5 mm, and set in the range of ⁇ 2.0 ⁇ LM ⁇ 2.0 mm. More preferably.
- the oscillating portion 60 when the oscillating portion 60 rides on the raised portion 36, the oscillating portion 60 bends inward in a substantially vertical direction with respect to the central axis of the shaft portion 51. Specifically, when the oscillating portion 60 rides on the raised portion 36, the flexible portion 60a including the inclined portion that is inclined outward with respect to the central axis of the shaft portion 51 in the natural state is bent, and the sliding portion 60b is the shaft. It is displaced inward in a substantially vertical direction with respect to the central axis of the portion 51.
- the prefilled syringe 1 generates a click sound and a click vibration almost simultaneously with the completion of the discharge of the drug solution 100, so that the anxiety as to whether or not the drug solution 100 is reliably administered to the recipient, In spite of being pushed out, the burden of pushing the pressing portion 54 unnecessarily with a higher pressing force than when the drug solution 100 is discharged is not caused to the administration person. Furthermore, even if the pressing portion 54 is about to be pulled back in the direction away from the opening 39, the sliding portion side step portion 63a is caught by the step portion 36a, so that the plunger 50 is positioned at the position shown in FIG. Cannot return to the position shown in FIG. Thereby, the oscillating unit 60 prevents erroneous determination that the prefilled syringe 1 is unused.
- a notch 39a that is recessed in a concave shape toward the tube tip 31.
- the inner diameter of the opening 39 is slightly larger than the outer diameter of the pressing part 54.
- the distance N from the surface on the proximal end side of the pressing portion 54 to the opening 39 is preferably substantially equal to the distances L and M.
- a substantially rectangular peep hole 32 penetrating the side wall of the outer cylinder 30 is formed (see FIG. 1).
- the peephole 32 is opened so that the gasket 43 that has reached the tip of the body portion 44 and the shaft portion 51 that is in contact with the gasket 43 are visible.
- the identification part 51a and the pressing part 54 enter the proximal end extension part 37a, the gasket 43 reaches the distal end of the body part 44, and the shaft part 51 Appearance changes such as being exposed through the peephole 32 occur.
- the administrator can recognize completion of the discharge of the drug solution 100 also by these plural appearance changes.
- the used prefilled syringe 1 from which the chemical solution 100 has been completely discharged must not be pierced by another recipient.
- the gasket 43 and the shaft part 51 exposed in the peephole 32 and the pressing part 54 concealed in the proximal end extension part 37a are not only for doctors who actually administer the medicinal solution 100 but also for nurses who handle the prefilled syringe 1 or the like. Since the medical staff's attention is drawn, a human error such as a puncture to another recipient can be surely prevented by visual inspection of a plurality of parties involved in the prefilled syringe 1.
- the thumb pressing the pressing portion 54 comes into contact with the notch portion 39a. Therefore, the administrator does not need to press the pressing portion 54 with the fingertip so that the angle of the thumb is changed just before the discharge of the drug solution 100 is completed and the pressing portion 54 is fitted into the inner space of the proximal end extension portion 37a.
- the prefilled syringe 1 makes it clear that it has been used and the discharge of the drug solution 100 has been completed by a change in appearance, and has both operability when administering the drug solution 100 to a recipient.
- the identification part 51a may be given a different color from the pressing part 54 and the proximal end extension part 37a so as to stand out.
- the finger hook portion 37b When the prefilled syringe 1 is placed on a table such as a treatment table, the finger hook portion 37b not only makes the finger contact when the drug solution 100 is administered, but it rolls and falls from the table. Is preventing.
- FIG. 3 shows an exploded perspective view of the prefilled syringe 1.
- the syringe barrel main body 40 has a chemical solution discharge portion 41 (see FIG. 2A) at the tip, a luer lock adapter 42 that surrounds a part of the side surface of the chemical solution discharge portion 41, an insertion port portion 46 at the base end,
- the syringe barrel flange 45 protrudes radially outward from the peripheral edge of the insertion port portion 46, and the body portion 44 is provided with an inner space between the drug solution discharge portion 41 and the insertion port portion 46.
- the syringe barrel flange 45 has a shape in which an outer edge viewed from the base end side has a major axis and a minor axis, and is located on a pair of major axis side surfaces 45a located on both sides in the major axis direction and on both sides in the minor axis direction. It has a pair of short axis direction side surfaces 45b.
- the pair of long-axis direction side surfaces 45a has an arc shape whose outer edge viewed from the base end side is centered on the central axis of the syringe barrel body 40, and the pair of short-axis direction side surfaces 45b has outer edges viewed from the base end side. It is a straight line parallel to the major axis direction.
- the pair of short-axis direction side surfaces 45b may be curved surfaces curved outward.
- the luer lock adapter 42 is a cylinder having a substantially hexagonal column shape, and the inner wall surface thereof is a female screw (see FIG. 2A).
- a male screw cap 21 or a hub 23 for sealing the chemical solution discharge portion 41 is detachably screwed onto the luer lock adapter 42.
- the outer cylinder 30 is formed of a translucent material so that the inner space of the outer cylinder 30 can be easily seen from the outside.
- the outer cylinder 30 has an annular protrusion 37 whose diameter is larger than that of the cylinder tip 31 and a hook-shaped finger hook part 37b protruding from the outer peripheral surface of the annular protrusion 37 at the base end thereof. Yes.
- the finger hook portion 37 b protrudes perpendicularly to the central axis of the outer cylinder 30 by extending along one direction in the radial direction substantially perpendicular to the central axis of the outer cylinder 30.
- the finger hook portion 37b includes two parallel straight portions that are tangent to the annular protrusion 37 that is parallel to the one direction, and a circular arc portion that is a concentric arc with the cylinder tip 31 that connects the straight portions. It has become.
- the finger hook portion 37 b protrudes only in one direction in the radial direction perpendicular to the central axis of the outer cylinder 30 on the outer peripheral surface of the annular projecting portion 37. For this reason, it is possible for the administrator to recall using the index finger, middle finger, ring finger, and little finger (see FIG. 5) at first glance.
- a pair of linear guide ribs 33 d are provided on the inner wall surface on the proximal end side of the outer cylinder 30 so as to protrude along the central axis of the outer cylinder 30.
- Two pairs of guide ribs 33 d are provided at positions facing each other across the central axis of the outer cylinder 30.
- the pair of guide ribs 33d includes a pair of base side guide rib 33d 2 extending from the vicinity of the annular projection 37 to the vicinity of the step portion 36a of the raised portion 36, the cylindrical tip 31 from the vicinity of the step portion 36a of the raised portion 36 and a pair of distal end side guide rib 33d 1 that towards extending.
- the distance between the pair of leading end side guide ribs 33 d 1 increases toward the tube leading end 31.
- the plunger 50 is inserted into the outer cylinder 30.
- Oscillating portion 60 can slide between a pair of base side guide rib 33d 2 while having a slight play. Accordingly, when the pressing portion 54 is pressed toward the tube tip 31, the oscillation portion 60 is guided toward the raised portion 36, and the rotation of the plunger 50 is suppressed. As a result, the oscillating portion 60 can reliably slide over the raised portion 36.
- the distance between the opposing guide ribs 33d is slightly larger than the width of the portion sandwiched between the opposing guide ribs 33d of the syringe barrel flange 45 and smaller than the width of the syringe barrel flange 45 in the major axis direction.
- a pair of rotation restricting ribs 33c are arranged at the distal ends of the pair of guide ribs 33d so as to face the short-axis side surface 45b of the syringe barrel flange 45 of the syringe barrel body 40 inserted into the outer barrel 30. It protrudes from the inner wall surface. Similar to the pair of guide ribs 33d, two pairs of rotation restricting ribs 33c are provided at positions facing each other across the central axis of the outer cylinder 30. Further, a total of four support protrusions 33b protrude toward the central axis of the outer cylinder 30 near the tips of the two pairs of rotation restricting ribs 33c. The support protrusion 33 b protrudes beyond the rotation restricting rib 33 c and supports the surface facing the tip of the syringe barrel flange 45 of the syringe barrel main body 40 inserted into the outer tube 30.
- inclination regulating ribs 33 a extending continuously from the support protrusions 33 b to the vicinity of the cylinder tip 31 protrude from the inner wall surface of the outer cylinder 30.
- Two sets of the inclination regulating ribs 33a are provided at positions facing each other across the central axis of the outer cylinder 30 with two adjacent pairs as a pair.
- the inclination regulating rib 33a can come into contact with the luer lock adapter 42 provided at the tip of the syringe barrel main body 40.
- the tip end portion of the inclination regulating rib 33 a is an abutting portion 33 a 1 that can abut on the luer lock adapter 42 of the syringe barrel body 40 inserted into the outer cylinder 30.
- the guide ribs 33d, the rotation restricting ribs 33c, the support protrusions 33b, and the inclination restricting ribs 33a are formed in a row, and the pair of ribs as a whole are positioned so as to face each other across the central axis of the outer cylinder 30. Two sets are provided.
- the guide rib 33d, the rotation restricting rib 33c, the support protrusion 33b, and the inclination restricting rib 33a may be formed discontinuously.
- the claw 35 protrudes from the inner wall surface of the outer cylinder 30 at a position shifted by 90 degrees in the circumferential direction of the outer cylinder 30 with respect to the raised portion 36.
- Two claws 35 are provided at positions facing each other across the central axis of the outer cylinder 30.
- the claw 35 is substantially perpendicular to the central axis of the outer cylinder 30 toward the cylinder tip 31 and the claw inclined surface 35b inclined so that the distance from the central axis of the outer cylinder 30 gradually decreases toward the cylinder tip 31. (See FIG. 4e).
- the locking surface 35 a has a locking projection 35 c that protrudes toward the tube tip 31.
- the outer cylinder 30 near the tip of each claw 35 is provided with two elastic deformation promotion holes 38 for facilitating elastic deformation of the vicinity of each claw 35 of the outer cylinder 30 radially outward.
- a rattling regulating rib 38 a extends from the tip of each claw 35 toward the tube tip 31. Since the rattling regulating ribs 38a are provided so as to cross the elastic deformation promotion holes 38, a total of four holes are opened in the outer cylinder 30.
- the syringe barrel flange 45 When the syringe barrel main body 40 is inserted into the outer barrel 30, the syringe barrel flange 45 is sandwiched and locked between the locking surface 35 a of the claw 35 and the support protrusion 33 b. Further, when the rattling regulating ribs 38 a come into contact with the respective long axis direction side surfaces 45 a of the syringe barrel flange 45, rattling in the major axis direction of the syringe barrel flange 45 with respect to the outer cylinder 30 is regulated. Furthermore, when the contact portion 33a 1 contacts the side surface of the luer lock adapter 42, the inclination of the syringe barrel body 40 with respect to the central axis of the outer tube 30 is restricted. As described above, in the prefilled syringe 1, rattling of the syringe barrel body 40 in the outer barrel 30 is restricted.
- the flange portions 52 and 53 are formed so as to protrude from the side surface of the shaft portion 51 one by one on the distal end side and the proximal end side of the oscillation portion 60. That is, the oscillating part 60 is sandwiched between the flange parts 52 and 53.
- the flange portions 52 and 53 are in contact with the inner wall surface of the outer cylinder 30 to suppress the inclination of the shaft portion 51 of the plunger 50 with respect to the central axis of the syringe barrel 10 (outer cylinder 30). Accordingly, even when the pressing portion 54 of the plunger 50 is pressed with a high pressing force, the shaft portion 51 is difficult to tilt with respect to the outer cylinder 30.
- the shaft 51 is supported so that the shaft 51 is not bent by the stress generated in the oscillating portion 60 and tilted with respect to the syringe barrel 10 even when the oscillating portion 60 gets over the raised portion 36.
- the pressing force applied to the pressing portion 54 is immediately applied to the central axis of the shaft portion 51, so that the gasket 43 can be slid smoothly.
- only one flange portion may be provided.
- at least one flange portion is provided on each of the distal end side and the proximal end side of the oscillation unit 60.
- the prefilled syringe 1 is supported so that the shaft portion 51 of the plunger 50 does not tilt with respect to the syringe barrel 10 when the drug solution 100 is discharged. Thereby, a deviation in timing between the completion of the discharge of the drug solution 100 and the generation of a click sound or the like caused by the tilt of the shaft portion 51 with respect to the syringe barrel 10 is prevented. Further, since the two flange portions 52 and 53 support the shaft portion 51 with the oscillating portion 60 interposed therebetween, the stress accumulated in the oscillating portion 60 does not work as a force that bends the shaft portion 51. For this reason, this stress is not attenuated and is accumulated exclusively as a force to play the oscillating unit 60. As a result, a problem that a click sound with a sufficient volume is not generated due to a lack of accumulated stress is prevented.
- the flange portions 52 and 53 regulate the rotation of the plunger 50 relative to the outer cylinder 30 by engaging with the guide rib 33d.
- the oscillating portion 60 with the rotation relative to the outer cylinder 30 of the plunger 50 abuts strongly with the proximal side rib 33d 2, is prevented from bent or broken oscillation section 60.
- the oscillation portion 60 is raised by the raised portion 36. Guided towards. That is, the guide rib 33d and the flange portions 52 and 53 function as a guide and a guide engaging portion for the oscillation portion 60 to guide toward the raised portion 36, respectively.
- the flange portion 52 has an engaging projection 52a that protrudes symmetrically across the central axis of the shaft portion 51 and is disposed between the pair of guide ribs 33d.
- the engagement protrusion 52a of the flange portion 52 gets over the raised portion 36 (see FIG. 1).
- the engaging protrusion 52a contacts and engages with the stepped portion 36a, so that it no longer gets over the raised portion 36.
- it is an unused prefilled syringe 1 it is prevented that the plunger 50 is accidentally detached from the outer cylinder 30 and dropped and contaminated.
- the prefilled syringe 1 has high safety.
- the plunger 50 is not connected to the gasket 43 as in this embodiment, the plunger 50 is prevented from being detached from the outer cylinder 30 by the engagement between the engagement protrusion 52a and the stepped portion 36a. Is effective.
- the outer shape of the flange portion 52 protruding from the tip side of the oscillation portion 60 is substantially rectangular.
- the plunger 50 may be inserted into and stored in the outer cylinder 30 in a direction in which the engagement protrusion 52a and the guide rib 33d are orthogonal to each other. Thereby, it can prevent that the axial part 51 of the plunger 50 bends or breaks at the time of storage or transportation. In addition, space can be saved when storing and transporting the outer cylinder 30 and the plunger 50 manufactured in advance.
- FIG. 4a A side view of the prefilled syringe 1 is shown in FIG. 4a, and a sectional view taken along the line AA is shown in FIG. 4b.
- a contact portion 33 a 1 provided at the tip of the inclination regulating rib 33 a faces the outer peripheral surface of the luer lock adapter 42 provided at the tip of the syringe barrel main body 40.
- the contact portion 33 a 1 protrudes toward the central axis of the outer cylinder 30.
- the contact portion 33 a 1 provided at the tip of the inclination regulating rib 33 a comes into contact with the outer peripheral surface of the luer lock adapter 42 toward the center axis of the outer cylinder 30, and the center axis of the outer cylinder 30.
- the inclination of the syringe barrel main body 40 with respect to can be reliably controlled.
- the distance between the pair of inclination regulating ribs 33 a and the two pairs of the inclined regulating ribs 33 a facing each other is shorter than the outer diameter of the luer lock adapter 42.
- provided at the tip portion of the inclined regulating ribs 33a abutting portion 33a 1 can more reliably restrict the inclination of the syringe barrel body 40 relative to the central axis of the outer cylinder 30.
- FIG. 4c shows a cross-sectional view taken along line BB in FIG. 4a.
- Two peep holes 32 are formed symmetrically with respect to the central axis of the outer cylinder 30 in a direction substantially perpendicular to the direction in which the two sets of inclination regulating ribs 33a face each other.
- the distance X between the two sets of inclination regulating ribs 33a facing each other across the central axis of the outer cylinder 30 is larger than the width Y of the viewing hole 32 in a cross section perpendicular to the central axis of the outer cylinder 30.
- FIG. 4d shows a cross-sectional view taken along the line CC in FIG. 4a.
- a pair of rotation restricting ribs 33 c face each of the pair of long side surfaces 45 a of the syringe barrel flange 45.
- the distance between the opposing rotation restriction ribs 33c is substantially equal to the width of the syringe barrel flange 45 between the opposite rotation restriction ribs 33c, and is smaller than the width of the syringe barrel flange 45 in the major axis direction.
- each of the two sets of rotation restricting ribs 33 c abuts on the respective long side surfaces 45 a of the syringe barrel flange 45, and the rotation of the syringe barrel body 40 with respect to the outer barrel 30 and the short axis of the syringe barrel flange 45. Shaking in the direction is regulated.
- the restricting protrusion 34 protrudes from the surface of each rotation restricting rib 33c facing the central axis of the outer cylinder 30.
- the restricting protrusion 34 is slightly crushed on the short-axis direction side surface 45 b of the syringe barrel flange 45. For this reason, rotation of the syringe barrel main body 40 with respect to the outer barrel 30 and rattling in the minor axis direction of the syringe barrel flange 45 are more reliably regulated.
- the rattling regulating rib 38a is opposed to each of the pair of long side surfaces 45a of the syringe barrel flange 45.
- the distance between the rattling regulating ribs 38a is substantially equal to the width of the syringe barrel flange 45 in the long axis direction. For this reason, each of the rattling regulating ribs 38a abuts on the respective short-axis direction side surfaces 45b of the syringe barrel flange 45, and rattling in the major axis direction of the syringe barrel flange 45 with respect to the outer barrel 30 is regulated. Yes.
- the finger hook portion 37 b has a straight portion parallel to one direction protruding from the outer wall surface of the outer cylinder 30 in the shape viewed from the central axis direction of the outer cylinder 30.
- the side surface of the finger hook portion 37 b has an arc portion that connects two straight portions along the outer periphery of the outer cylinder 30, and the distance between the two straight portions is equal to the width of the annular projecting portion 37. It is almost equal. For this reason, the direction of the outer cylinder 30 can be easily regulated by the parts feeder of the production line.
- FIG. 4e shows a partial enlarged view taken along the line DD in FIG. 4a.
- the locking surface 35 a of the claw 35 has a locking projection 35 c protruding toward the cylinder tip 31.
- the locking protrusion 35c is pressed against the proximal end side surface of the syringe barrel flange 45 and is slightly crushed. As a result, there is no play between the claw 35 and the syringe barrel flange 45, and rattling of the syringe barrel body 40 with respect to the outer tube 30 in the central axis direction of the outer tube 30 is reliably prevented.
- the prefilled syringe 1 is manufactured as follows. First, the syringe barrel body 40 molded by injection molding or the like, the luer lock adapter 42, and the cap 21 are prepared. The luer lock adapter 42 is fitted into the chemical solution discharge portion 41 so that a part of the side surface of the chemical solution discharge portion 41 is surrounded. Further, the cap 21 is screwed onto the luer lock adapter 42 and attached. The syringe barrel main body 40 is suspended from a storage container (not shown) and subjected to sterilization such as high-pressure steam sterilization.
- a chemical solution supply nozzle (not shown) is inserted into the insertion port 46 of the syringe barrel body 40 to inject the desired drug solution 100 into the syringe barrel body 40. Further, the gasket 43 is inserted into the syringe barrel main body 40 to seal the drug solution 100 in a liquid-tight manner. Thereby, the chemical solution 100 in the syringe barrel main body 40 is prevented from leaking or being contaminated when the prefilled syringe 1 is transported or stored.
- molded by injection molding etc. is prepared.
- the outer cylinder 30 having the peep hole 32 is molded.
- the syringe barrel main body 40 containing the drug solution 100 is inserted into the outer barrel 30 so that the short-axis direction side surface 45b of the syringe barrel flange 45 faces the guide rib 33d.
- the direction of the outer cylinder 30 and the syringe barrel body 40 can be easily matched using the straight portion of the finger hook portion 37b and the short-axis direction side surface 45b of the syringe barrel flange 45.
- the side surface 45b in the short axis direction of the syringe barrel flange 45 is guided by the guide rib 33d, and the syringe barrel main body 40 is inserted into the outer barrel 30 without rotating. Further, the tapered guide portion 33d 3 provided on the proximal end of the guide rib 33d (base end side guide rib 33d 2), syringe flange 45 is inserted smoothly between opposing guide ribs 33d.
- the syringe barrel main body 40 is pushed in until the syringe barrel flange 45 gets over the claw 35 and is sandwiched and locked between the support protrusion 33b and the claw 35. Thereby, the syringe barrel main body 40 is locked to the outer barrel 30 so that it cannot be removed therefrom.
- the outer barrel 30 is slightly deformed radially outward by the buffering action of the elastic deformation promotion hole 38. Thereby, the syringe barrel flange 45 can be overcome without crushing the claw 35. Further, the syringe barrel flange 45 can easily get over the claw 35 by the claw inclined surface 35 b of the claw 35.
- the outer cylinder 30 has a portion extending from the periphery of the insertion port portion 46 of the syringe barrel main body 40 toward the proximal end side.
- a plunger 50 having a shaft portion 51, flange portions 52 and 53, a pressing portion 54, and an oscillating portion 60 molded by injection molding or the like is prepared. While the shaft portion 51 is inserted from the insertion port portion 46 of the syringe barrel body 40, the engagement protrusion 52a of the flange portion 52, the guide engagement portion 53a of the flange portion 53, and the oscillation portion 60 are disposed between the pair of guide ribs 33d. The plunger 50 is inserted into the syringe barrel 10 through the opening 39 of the outer tube 30 as described above.
- the guide taper portion 33d 3 provided on the proximal end of the guide rib 33d (base end side guide rib 33d 2), flange portions 52 and 53 is inserted smoothly between opposing guide ribs 33d.
- the guide rib 33d may not extend to the vicinity of the opening 39 of the outer cylinder 30 so that the flange portion 53 is not inserted between the opposing guide ribs 33d.
- the plunger 50 is pushed in until the engaging protrusion 52 a gets over the raised portion 36, and the distal end surface of the shaft portion 51 of the plunger 50 and the proximal end surface of the gasket 43 are brought into contact with each other. In this way, the prefilled syringe 1 is completed.
- the prefilled syringe 1 has a shape in which the distal end of the shaft portion 51 of the plunger 50 and the proximal end of the gasket 43 do not come into contact until the plunger 50 starts moving toward the tube distal end 31 by a pressing operation on the pressing portion 54. It may be.
- Such a shape can be realized, for example, by extending the raised portion 36 to the vicinity of the opening 39 of the outer cylinder 30 and supporting the sliding portion 60b of the oscillating portion 60 with the raised portion 36. As a result, rattling of the plunger 50 in the syringe barrel 10 is prevented when the prefilled syringe 1 is transported or stored.
- the obtained prefilled syringe 1 is airtightly stored in a box-shaped blister packaging material or bag-shaped packaging material having a film lid.
- the prefilled syringe 1 is sterilized together with the packaging material.
- the injection needle 22 is fixed to the hub 23 formed by injection molding or the like, or the hub 23 is injection molded together with the injection needle 22 to produce the hub 23 with the injection needle 22.
- the hub 23 is covered with a cover (not shown) so that the injection needle 22 is protected if necessary, and is airtightly stored in a cup-shaped blister packaging material and sterilized.
- the oscillating unit 60 is preferably molded into a thin plate having a thickness of 0.5 to 1.5 mm. If the thickness is smaller than this range, the oscillator 60 is broken due to the stress generated when the bump 36 is overcome. On the other hand, if it is thicker than this range, a very high pressing force is required to bend the flexible portion 60a.
- the height of the stepped portion 36a of the raised portion 36 is preferably at least 0.5 mm. As a result, a sufficient amount of stress is accumulated in the oscillating portion 60, so that when the oscillating portion 60 gets over the raised portion 36, click sound and click vibration are reliably generated.
- the height of the stepped portion 36a is preferably smaller than half of the difference between the inner diameter of the outer cylinder 30 and the inner diameter of the syringe barrel body 40. Thereby, when inserting the front-end
- a taper 37c (see FIG. 2A) in which the distance from the central axis of the outer cylinder 30 is gradually narrowed toward the cylinder tip 31 is formed on the inner wall surface of the annular protrusion 37.
- the taper 37c may be formed at regular intervals along the inner wall surface of the annular protrusion 37 as shown in FIG.
- the syringe barrel main body 40 when the syringe barrel main body 40 is inserted into the outer cylinder 30 due to the taper 37 c, the syringe barrel flange 45 is smoothly guided to the distal end side by the annular projecting portion 37. Therefore, the syringe barrel main body 40 can be smoothly inserted into the outer barrel 30.
- the usage method of the prefilled syringe 1 will be described with reference to FIG.
- the doctor or nurse peels off the mount of the blister packaging material, takes out the prefilled syringe 1, and removes the cap 21 that seals the chemical solution discharge part 41.
- the film lid of the cup-shaped blister packaging material in which the hub 23 with the injection needle 22 is accommodated is peeled off, and the hub 23 is screwed into the luer lock adapter 42 together with the cup-shaped blister packaging material container in place of the cap 21. Install them together.
- the rotation restriction rib 33c of the outer cylinder 30 restricts the rotation of the syringe barrel body 40 relative to the outer cylinder 30, so the luer lock adapter 42 does not rotate together with the hub 23, and the luer lock adapter 42
- the hub 23 can be reliably screwed together.
- a part of the luer lock adapter 42 protrudes from the tube tip 31. For this reason, it is possible to make the user recognize that the hub is attached by screwing.
- the injection needle 22 is repelled from contamination until just before the administration of the drug solution 100 because the hub 23 is accommodated in the cup-shaped blister packaging material container and attached to the drug solution discharge part 41 without being taken out.
- the user can confirm that the prefilled syringe 1 is not used by visually recognizing the position of the gasket 43 and the presence of the drug solution 100 through the peephole 32.
- the administrator removes the cup-shaped blister packaging material container, and then holds the outer cylinder 30 so that the little finger is on the hub 23 side and the index finger is on the finger hooking portion 37b side while the thumb is applied to the pressing portion 54. .
- the annular stabilizing portion 23a is brought into contact with the skin to be injected by the recipient and supported so as not to move, and is further pressed and stabilized.
- the injection needle 22 is punctured into the skin of the recipient.
- the injection needle 22 is reliably punctured into the skin by pressing the annular stabilizing portion 23a of the hub 23 against the skin in this way.
- the drug solution 100 does not leak from the tip of the needle 22.
- the abutment portion 33a 1 of the inclined regulating rib 33a comes into contact with the outer peripheral surface of the luer lock adapter 42, the slope of the syringe barrel body 40 relative to the central axis of the outer cylinder 30 is restricted. Thereby, the injection needle 22 can be stably punctured to the target site.
- the pressing portion 54 is pressed toward the tube tip 31 to move the plunger 50 in the tip direction.
- the gasket 43 is pushed by the plunger 50 and slides toward the chemical solution discharge portion 41, and the chemical solution is discharged from the chemical solution discharge portion 41.
- the drug solution discharged from the drug solution discharge unit 41 is administered to the administration subject through the injection needle of the hub.
- the finger hooking portion 37b abuts on the index finger, so that the finger holding the outer cylinder 30 is prevented from further shifting to the base end side with respect to the outer cylinder 30.
- the index finger is not pinched between the opening 39 and the pressing portion 53, and the thumb is not in contact with the side surface of the index finger, the plunger 50 is pushed out, and the prescribed amount of the chemical solution 100 is reliably injected into the skin.
- the notch part 39a is provided in the base end extension part, the first joint of the thumb is difficult to interfere with the base end extension part 37a. For this reason, the administration person can push the plunger 50 completely.
- the tilt of the syringe barrel body with respect to the central axis of the outer cylinder is regulated by the contact portion of the tilt regulating rib, the drug solution 100 can be stably administered to the recipient.
- the drug solution 100 can be stably administered to the recipient.
- Can also be administered for the inclination of the syringe barrel body 40 relative to the central axis of the outer cylinder 30 is restricted by the abutment portion 33a 1 of the inclined regulating ribs 33a, more stably the drug solution 100 to the recipient.
- the sliding portion side inclined surface 63b slides on the raised portion side inclined surface 36c, and stress is accumulated in the oscillation portion 60.
- the oscillating unit 60 gets over the top 36b of the raised portion 36, the stress accumulated in the oscillating unit 60 is released, and the oscillating unit 60 is repelled to generate click sound and click vibration. .
- the administration person senses the click sound and the click vibration to confirm that the drug solution 100 is discharged from the syringe barrel body 40 and the administration to the administration person is completed.
- the administration force is applied so as to push down the pressing portion 54 of the plunger 50, and the administration is held for several seconds to complete administration to the administration subject.
- FIGS. 6a to 6d show front views of other forms of the oscillation unit 60.
- FIG. 6 a a plurality of oscillation parts 60 having the same shape may protrude from the side surface of the shaft part 51 so as to correspond to the pair of raised parts 36 (see FIG. 2). If a pair of raised portions 36 and a pair of oscillating portions 60 corresponding thereto are provided in this way, it is possible to generate louder sounds and vibrations than the click sound generated by one oscillating portion 60. Even when the surroundings are noisy, such as when many people are waiting for a group vaccination, the administra- tor can reliably hear the click sound.
- the shape of the oscillating portion 60 can be simplified, so that the prefilled syringe 1 can be manufactured at low cost.
- the oscillating unit 60 may not have the proximal end side flexible unit 62. Since the oscillating part 60 is connected to the side surface of the shaft part 51 only by the branch part 61a, it is only necessary to press the pressing part 54 with a small force to bend the oscillating part 60. Therefore, it is possible to reduce the burden on the administrator.
- the oscillation part 60 may be composed of an arch part 62a and a sliding part 60b.
- the accumulated stress can be dispersed to reduce distortion remaining in the oscillating unit 60.
- the shape, material, thickness, hardness, and the like of the oscillating unit 60 shown in FIGS. 1 and 6a to 6d are appropriately selected according to the pressing force of the pressing unit 54 that varies depending on the type and amount of the chemical solution 100.
- the guide engaging portion is preferably a concave portion provided on the flange portion 52 and sandwiching one guide rib 33d.
- One guide groove may be provided on the filament along the central axis of the outer cylinder 30.
- the guide engaging portion is a protrusion that protrudes from the shaft portion 51 of the plunger 50 and is inserted into the guide groove.
- FIG. 7A shows a partially exploded perspective view of another form of the prefilled syringe 1.
- FIG. 1 shows a state in which a part of the label 60 is peeled off from the wall portion of the outer cylinder 30.
- the prefilled syringe 1 has a mark member 72 a in the middle of the shaft portion 51.
- the mark member 72 a is a disc extending outward from the outer periphery of the shaft portion 51.
- the outer diameter of the mark member 72 a is smaller than the inner diameter of the outer cylinder 30. Since the mark member 53 is molded with a red resin, the entire surface thereof is a mark portion 72 for allowing a medical worker to recognize that the prefilled syringe 1 is used.
- a hole is formed in the center of the mark member 72. The inner diameter of this hole is slightly smaller than the outer diameter of the distal end portion of the shaft portion 51 with which the gasket 43 abuts.
- the mark member 72 a When the tip of the shaft portion 51 is pushed into the hole of the mark member 72a, the hole is slightly widened and the shaft portion 51 is fitted. Thereby, the mark member 72 a is attached to the shaft portion 51. Since the mark member 72a is formed of resin, it has some flexibility. Therefore, the mark member 72a generates stress in the direction in which the shaft portion 51 is tightened. The marker member 72 a is fixed to the shaft portion 51 by this stress.
- the mark member 72a may be integrally formed with the plunger 50, may be formed in two colors at that time, or may be colored by painting and labeling thereafter.
- the label 70 is wound around the outer cylinder 30 so as not to cover the finger hook portion 37 b and the proximal end extension portion 37 a near the proximal end of the outer cylinder 30, and covers the outer cylinder 30.
- the label 70 is a substantially rectangular sheet having a side 70a along the central axis and a side 70b along the circumferential direction when the label 70 is opened along the central axis of the outer cylinder 30 and developed.
- the length of the side 70 a is slightly longer than half of the entire length of the outer cylinder 30.
- the length of the side 70b adjacent to the side 70a is slightly longer than the length of the outer cylinder 30 in the circumferential direction.
- the label 70 is made of a transparent film, and the entire surface is printed opaque.
- a band-shaped window forming transparent portion 71a that is not printed in parallel with the side 70b closer to the tip than the middle is provided.
- the label 70 is divided by the window forming transparent portion 71a to form a distal-side opaque portion 70c on the distal end side and a proximal-side opaque portion 70d on the proximal end side.
- the background color for printing the label 70 is a color different from the mark portion 72, for example, a complementary color of white or red, or a color similar thereto. Thereby, the background color of the label 70 makes the mark portion 72 stand out.
- the distances L, M, N, and the distance P from the surface on the distal end side of the mark member 72a to the edge on the distal end side of the window portion 71 are substantially equal. Further, the width of the window portion 71 and the width of the side surface of the mark member 72a are substantially equal.
- FIG. 7B shows a state immediately before the prefilled syringe 1 is used.
- a rectangular label 70 is wound and stuck on the outer wall surface of the outer cylinder 30.
- the opaque portion of the label 70 hides the mark portion 72.
- the mark member 72a is stationary before the drug solution 100 is discharged, with the mark portion 72 not being visually recognized.
- the prefilled syringe 1 in which the mark portion 72 is not visible indicates that it is unused.
- a hub 23 is attached to the luer lock adapter 42 instead of the cap 21.
- FIG. 7C shows a state after the prefilled syringe 1 is used. Since the distances L, M, N, and P are substantially equal, a click sound or the like is generated almost simultaneously with the completion of the discharge of the chemical solution 100, the shaft portion 51 is exposed through the viewing hole 32, and the pressing portion 54 is exposed to the proximal end extending portion 37a. The mark portion 72 is visually recognized from the window portion 71. These clearly indicate the use of the prefilled syringe 1.
- FIG. 8 shows a partially exploded perspective view of another form of the prefilled syringe 1.
- the syringe barrel 10 of the prefilled syringe 1 shown in the figure is one in which an outer barrel 30 and a syringe barrel body 40 are integrated.
- the outer cylinder 30 extends from the periphery of the insertion port portion 46 of the syringe barrel body 40 toward the opening 39, and is provided at an inner diameter larger than the inner diameter of the syringe barrel body 40 and on the proximal end side of the insertion port portion 46.
- a raised portion 36 is provided.
- the outer cylinder 30 has a diameter-expanded portion 30a that is expanded from the periphery of the insertion port portion 46 toward the opening 39, and is connected to the syringe barrel main body 40 through the diameter-expanded portion 30a. ing.
- a through hole 30b forming the stepped portion 36a is opened symmetrically with respect to the central axis of the enlarged diameter portion 30a.
- the distances L, M, and P are substantially equal to each other. Therefore, the marker member 72 is exposed from the window 71 at the same time as the discharge of the chemical solution 100 is completed, and the oscillating unit 60 is repelled to generate click sound and click vibration. .
- FIG. 9 a shows a partially exploded perspective view of another form of the prefilled syringe 1.
- the prefilled syringe 1 includes an injection cylinder 10, a plunger 50, and an adapter 80, and does not have an outer cylinder 30.
- the shaft portion 51 has a cross-shaped cross section.
- One of the protrusions forming the cross shape is an engaging protrusion 86.
- the oscillating portion 60 protrudes from the shaft portion 51 in tandem with the engaging protrusion 86.
- the oscillation part 60 protrudes from the engagement protrusion 86.
- the adapter 80 has an arc shape, and has a notch portion 81 having an open arc and a finger hook portion 84 protruding larger in two opposing directions. Furthermore, the adapter 80 has a concave portion 82 that is recessed on the inner wall surface thereof, and a slit 83 that is formed by passing through a surface facing the notch portion 81.
- the adapter 80 is roughly divided into a front surface 83a facing the chemical solution discharge portion 41 and a back surface 83b facing the pressing portion 54 with the slit 83 interposed therebetween.
- the adapter 80 is deformed when the notch 81 is widened, and the syringe barrel flange 45 is fitted into the recess 82 and the slit 83.
- the adapter 80 is attached to the syringe barrel main body 40.
- the adapter 80 has some flexibility because it is molded of resin. As a result, even if a force for expanding the notch 81 is applied, the adapter 80 returns to its original shape by being removed after being attached to the syringe barrel flange 45.
- the outer shape of the syringe barrel flange 45 is circular so that the adapter 80 can be easily attached.
- FIG. 9b shows a cross-sectional view taken along line AA in FIG. 9a.
- a pair of guide ribs 85 protrudes from the inner periphery of the back surface 83b.
- the engaging protrusion 86 is sandwiched between the guide ribs 85.
- a raised portion 87 protrudes on an extension line on the proximal end side of the guide rib 85.
- FIG. 9c shows a partial cross-sectional view taken along line BB in FIG. 9a.
- the engaging protrusion 86 slides between the pair of guide ribs 85 when the pressing portion 54 is pressed toward the chemical solution discharging portion 41. Thereby, the rotation of the plunger 50 is prevented, so that the oscillating portion 60 is smoothly guided to the raised portion 87.
- the prefilled syringe 1 generates a click sound and a click vibration when the oscillating unit 60 gets over the raised portion 87 almost simultaneously with the completion of the discharge of the chemical solution 100.
- the administrator administers the medicinal solution 100 to the administration subject by hooking the index finger and the middle finger on the finger hook portion 84 of the adapter 80 and pressing the pressing portion 54 with the thumb.
- the drug solution 100 contained in the syringe barrel 40 includes, for example, influenza, tetanus, pneumococci, polio, Japanese encephalitis, rubella, measles, yellow fever, hives, hepatitis, chickenpox, rabies, rotavirus, mumps, and cervix.
- Biopharmaceuticals such as vaccines such as cancer prevention, MQ, DT and DPT.
- Other than vaccines for example, sugar solution injection solutions such as glucose, electrolyte correction injection solutions such as sodium chloride and potassium lactate, contrast agents, steroid agents, proteolytic enzyme inhibitors, fat emulsions, antibiotics, anticancer agents, heparin Examples include calcium, anesthetics and antibody drugs.
- the pressing force which pushes the plunger 50 is usually less than 5N.
- the pressing force for pushing the plunger 50 is 5 N or more, the administrator pushes the plunger 50 with a pressing force higher than usual. For this reason, it is impossible to clearly sense the response to the completion of discharge that occurs when the gasket 43 hits the tip of the inner wall of the syringe barrel main body 40.
- the administrator administers the work load of pushing the plunger 50 unnecessarily with a pressing force exceeding that at the time of administration, even though the drug solution 100 is completely discharged. It will be owed to the person.
- the prefilled syringe 1 when the pressing force which pushes the plunger 50 becomes 5N or more.
- the pressing force is about 15 N or more, and thus this prefilled syringe 1 is particularly preferable.
- the prefilled syringe 1 may be sterilized using any one of autoclave sterilization, ethylene oxide gas, ⁇ rays, and electron beams.
- the materials of the cap 21, the hub 23, the outer cylinder 30, the syringe barrel main body 40, the plunger 50, and the adapter 80 are selected from the viewpoints of chemical resistance, gas / bacteria barrier properties, safety to living bodies, and the like.
- polyolefin resin such as polyethylene, polypropylene and cyclic polyolefin; polystyrene; polycarbonate; polyester such as polyethylene terephthalate;
- a resin having high heat resistance such as polypropylene or polycarbonate, as these materials.
- the syringe barrel main body 40 As a material of the syringe barrel main body 40, it has high transparency so that the drug solution 100 accommodated in the tube can be visually recognized from the outside, has little interaction with the drug solution 100, and is strongly gripped when the drug solution 100 is administered. It is preferable to use a cyclic olefin homopolymer or a cyclic olefin copolymer, which is a resin that does not bend and is not crushed when pressed or pushed. As a molding method of each member used in the prefilled syringe 1, a blow molding method, a thermoforming method, or the like can be used in addition to the injection molding method.
- the material of the gasket 43 is selected from the same viewpoint as described above.
- rubber materials such as olefin-based, polyurethane-based, polyester-based, polyamide-based or styrene-based thermoplastic elastomers, natural rubber, isoprene rubber, butadiene rubber, styrene-butadiene rubber, and silicone rubber are used.
- the material of the label 70 can be polyolefin such as polyethylene or polypropylene; polyvinyl chloride; polystyrene; polyethylene terephthalate; paper.
- the window portion 71 can be formed by connecting opaque labels arranged in a width to form the window portion 71 with a transparent film.
- the window portion 71 may be formed by masking a portion where the window portion 71 of the outer cylinder 30 is to be formed and coating the outer peripheral surface of the outer tube 30 and then removing the masking.
- the prefilled syringe of the present invention is used for administering a drug solution to a patient or a recipient of a vaccine.
Abstract
Description
Claims (23)
- 先端に薬液排出部と基端に開口部とが設けられた注射筒と、
前記注射筒に着脱自在に装着され、前記薬液排出部を封止しているキャップと、
前記注射筒に挿入されているガスケットと、
前記開口部から前記注射筒に挿入される軸部と、前記軸部の基端に設けられ、人の手で押圧される押圧部とを有し、前記押圧部への押圧操作によって先端方向に移動することにより前記ガスケットを前記薬液排出部に向かって摺動させるプランジャと、
前記注射筒内で前記薬液排出部と前記ガスケットとの間に収容され、前記ガスケットの摺動により前記薬液排出部から排出される薬液とを、
備えるプレフィルドシリンジであって、
前記ガスケットと前記開口部との間の前記注射筒の内壁面で、前記注射筒の中心軸に対して略垂直に突き出た段差部を有する隆起部と、
前記軸部の側面から突き出て、前記プランジャの先端方向への移動に応じて前記隆起部を摺動しつつ前記隆起部に乗り上げることにより前記軸部の中心軸に対して略垂直方向内向きに撓み、前記薬液の排出完了とほぼ同時に前記隆起部を乗り越えることにより弾かれてクリック音及び/又はクリック振動を発生させる発振部とを、
有することを特徴とするプレフィルドシリンジ。 - 前記段差部の高さが、少なくとも0.5mmであることを特徴とする請求項1に記載のプレフィルドシリンジ。
- 前記発振部が前記隆起部を乗り越えるまでの前記プランジャの移動距離Mと前記薬液の排出完了までの前記ガスケットの摺動距離Lとの差が、-3.0mm≦L-M≦3.0mmであることを特徴とする請求項1又は2に記載のプレフィルドシリンジ。
- 前記発振部が、前記軸部の側面から枝分かれして突き出ており、自然状態において前記軸部の中心軸に対し外向きに傾斜した傾斜部を有する可撓部と、
前記可撓部に繋がっており、前記隆起部上を摺動する摺動部とを、
有することを特徴とする請求項1から3のいずれかに記載のプレフィルドシリンジ。 - 前記摺動部が、基端に前記軸部の中心軸に対して略垂直な摺動部側段差部を有していることを特徴とする請求項4に記載のプレフィルドシリンジ。
- 前記可撓部が、前記摺動部よりも先端側の前記軸部の側面から枝分かれして突き出て、前記摺動部へ向かって延び、前記傾斜部を含む先端側可撓部を有していることを特徴とする請求項4又は5に記載のプレフィルドシリンジ。
- 前記先端側可撓部が前記軸部の側面から枝分かれした位置よりも基端側の前記軸部の側面から枝分かれして突き出て、前記摺動部に繋がり、前記傾斜部を含む基端側可撓部を、前記可撓部が、さらに有していることを特徴とする請求項6に記載のプレフィルドシリンジ。
- 前記基端側可撓部が、前記摺動部よりも基端側の前記軸部の側面から枝分かれして突き出ていることを特徴とする請求項6に記載のプレフィルドシリンジ。
- 前記可撓部が、前記軸部の側面に繋がっている一端と前記摺動部に繋がっている他端との間に、湾曲及び/又は屈曲した複数のアーチ部を有し、前記アーチ部の少なくとも一部が前記傾斜部を含んでいることを特徴とする請求項4又は5に記載のプレフィルドシリンジ。
- 前記アーチ部が前記一端側に前記軸部の側面を基準として凸状に反った第1アーチ部と、
前記他端側に前記第1アーチ部と逆向きに反った第2アーチ部とを、
有していることを特徴とする請求項9に記載のプレフィルドシリンジ。 - 前記摺動部よりも先端側の前記軸部の側面から枝分かれして突き出て、前記摺動部へ向かって延び、前記傾斜部を含む先端側可撓部と、
前記摺動部よりも基端側の前記軸部の側面から枝分かれして突き出て、前記アーチ部を有しつつ前記摺動部へ繋がっている基端側可撓部とを、
前記可撓部が、有していることを特徴とする請求項9又は10に記載のプレフィルドシリンジ。 - 前記基端側可撓部が、前記摺動部よりも基端側の前記軸部の側面に繋がっていることを特徴とする請求項10に記載のプレフィルドシリンジ。
- 前記軸部の中心軸に対して垂直な方向に前記軸部の側面から枝分かれした分枝部と、
前記分枝部から基端方向に延びて前記摺動部に繋がり、基端方向に向かうにつれて前記軸部の側面との距離が漸次長くなる前記傾斜部とを、
前記先端側可撓部が、有していることを特徴とする請求項11又は12に記載のプレフィルドシリンジ。 - 前記摺動部が、前記軸部の先端に向かうにつれて前記軸部の側面との距離が漸次短くなる摺動部傾斜面を有していることを特徴とする請求項4から13のいずれかに記載のプレフィルドシリンジ。
- 前記隆起部が、前記注射筒の先端に向かうにつれて前記注射筒の中心軸との距離が漸次短くなる摺動部傾斜面を有していることを特徴とする請求項1から14のいずれかに記載のプレフィルドシリンジ。
- 前記軸部の側面から突き出て、前記注射筒の内壁面に当接することにより前記注射筒の中心軸に対する前記プランジャの傾きを抑制するフランジ部を、前記プランジャが有していることを特徴とする請求項1から15のいずれかに記載のプレフィルドシリンジ。
- 前記フランジ部は、前記発振部よりも先端側及び基端側に少なくとも1つずつ設けられていることを特徴とする請求項16に記載のプレフィルドシリンジ。
- 先端に前記薬液排出部と基端に開口した挿入口部とを有し、前記ガスケットが挿入されている注射筒本体と、
少なくとも一部が前記挿入口部の周囲から基端側に延び、基端に前記開口部が設けられ、前記挿入口部の周囲から前記開口部にかけて前記注射筒本体の内径よりも大きな内径と、前記挿入口部よりも基端側に設けられた前記隆起部とを有する外筒とを、
前記注射筒が備えており、
前記段差部の高さは、前記外筒の内径と前記注射筒本体の内径との差の半分より小さいことを特徴とする請求項1から17のいずれかに記載のプレフィルドシリンジ。 - 前記外筒の内壁面には、前記外筒の中心軸に沿って線条に形成されたガイドリブ又はガイド溝が形成され、
前記プランジャの前記軸部には、前記ガイドリブ又は前記ガイド溝に係合することにより、前記プランジャの回動を抑止して前記発振部を前記隆起部に導くガイド係合部が設けられていることを特徴とする請求項18に記載のプレフィルドシリンジ。 - 前記プランジャは、前記軸部の前記注射筒本体に挿入される部分と前記発振部との間の前記軸部から突き出した係合突起を有し、
前記プランジャが前記開口部から前記外筒内に挿入される際に、前記係合突起が前記隆起部を乗り越えて前記段差部と係合することにより、再使用が防止されることを特徴とする請求項18又は19に記載のプレフィルドシリンジ。 - 前記注射筒は、前記挿入口部の周縁から突き出た注射筒フランジを有する前記注射筒本体と、前記注射筒本体が挿入された前記外筒とを備え、
前記外筒は、前記外筒の内壁面から突き出て、前記注射筒フランジの先端面を支持する支持突起と、前記隆起部と周方向に異なる位置で前記外筒の内壁面から突き出た爪とを有し、
前記注射筒フランジが、前記支持突起と前記爪とに挟まれて係止されていることを特徴とする請求項20に記載のプレフィルドシリンジ。 - 前記プランジャは、前記ガスケットに固着されておらず、前記プランジャの先端を前記ガスケットの基端に当接させることで前記ガスケットを前記薬液排出部に向かって摺動させるものであり、
前記発振部は、前記隆起部を乗り越えた後に前記段差部と係合することにより、前記プランジャが元の位置に戻ることを防止することを特徴とする請求項19から21のいずれかに記載のプレフィルドシリンジ。 - 前記薬液を皮内へ投与するために用いられることを特徴とする請求項1から19のいずれかに記載のプレフィルドシリンジ。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15774457.4A EP3127572B1 (en) | 2014-03-31 | 2015-03-03 | Prefilled syringe |
JP2016511476A JP6499158B2 (ja) | 2014-03-31 | 2015-03-03 | プレフィルドシリンジ |
US15/280,637 US10625025B2 (en) | 2014-03-31 | 2016-09-29 | Prefilled syringe |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014-074958 | 2014-03-31 | ||
JP2014074958 | 2014-03-31 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/280,637 Continuation US10625025B2 (en) | 2014-03-31 | 2016-09-29 | Prefilled syringe |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015151693A1 true WO2015151693A1 (ja) | 2015-10-08 |
Family
ID=54240026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2015/056188 WO2015151693A1 (ja) | 2014-03-31 | 2015-03-03 | プレフィルドシリンジ |
Country Status (4)
Country | Link |
---|---|
US (1) | US10625025B2 (ja) |
EP (1) | EP3127572B1 (ja) |
JP (1) | JP6499158B2 (ja) |
WO (1) | WO2015151693A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018037034A1 (en) * | 2016-08-26 | 2018-03-01 | Sanofi-Aventis Deutschland Gmbh | Audible indicator |
WO2018037030A1 (en) * | 2016-08-26 | 2018-03-01 | Sanofi-Aventis Deutschland Gmbh | Audible indicator |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6752775B2 (ja) * | 2015-03-24 | 2020-09-09 | テルモ株式会社 | シリンジホルダ及び薬液投与セット |
KR102039811B1 (ko) * | 2015-04-24 | 2019-11-01 | 에스에이치엘 메디컬 아게 | 약물 전달 장치의 서브-조립체 및 약물 전달 장치 |
GB2563029B (en) | 2017-05-30 | 2022-06-08 | Janssen Pharmaceuticals Inc | Grip accessory for a manual injection device |
GB2563027B (en) | 2017-05-30 | 2022-04-06 | Janssen Pharmaceuticals Inc | Grip accessory for a manual injection device |
USD888941S1 (en) | 2017-11-30 | 2020-06-30 | Janssen Pharmacauticals, Inc. | Grip accessory for a manual injection device |
AU2017100682A4 (en) * | 2017-07-13 | 2018-01-18 | Cachia, Helen MRS | This invention is a tool for aiding in the positioning of injections/needles. More specifically, it controls the angle, depth and movement for an accurate injection. Which in turn, reduces the risks, pain and improves needle penetration. The design specifications will vary to suit different injection devices. Obviously these will alter depending on the different type and brand of injection/pen. This includes the width,height,depth, colour and shape.The external design will remain the same but open for option. |
USD946750S1 (en) | 2018-07-11 | 2022-03-22 | Janssen Pharmaceuticals, Inc. | Grip accessory for an injection device |
US20220225624A1 (en) * | 2021-01-20 | 2022-07-21 | Yuyao Wandaifu Barbecue Tools Factory | Flavor injector |
CN112999468B (zh) * | 2021-02-09 | 2023-07-04 | 上海康德莱医疗器械股份有限公司 | 一种安全注射器 |
WO2022178196A1 (en) | 2021-02-19 | 2022-08-25 | Sanofi Pasteur Inc. | Meningococcal b recombinant vaccine |
WO2023174668A1 (en) * | 2022-03-14 | 2023-09-21 | Shl Medical Ag | Sub-assembly for a medicament delivery device |
WO2024030931A1 (en) | 2022-08-03 | 2024-02-08 | Sanofi Pasteur Inc. | Adjuvanted immunogenic composition against neisseria meningitidis b |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007159717A (ja) * | 2005-12-12 | 2007-06-28 | Maeda Sangyo Kk | 注射器 |
JP2008073519A (ja) * | 2006-08-25 | 2008-04-03 | Dainippon Sumitomo Pharma Co Ltd | 注射器及びプランジャロッド |
US20080132852A1 (en) * | 2004-07-28 | 2008-06-05 | Kleyhan Gennady I | Dosage device |
JP2012139330A (ja) * | 2010-12-28 | 2012-07-26 | Yoshino Kogyosho Co Ltd | シリンジ容器 |
WO2014045405A1 (ja) * | 2012-09-21 | 2014-03-27 | テルモ株式会社 | 薬剤投与器具 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5380295A (en) * | 1992-12-14 | 1995-01-10 | Mallinckrodt Medical, Inc. | Delivery apparatus with mechanism preventing rearward movement of a piston disposed therein |
WO2001062319A2 (en) * | 2000-02-23 | 2001-08-30 | Abbott Laboratories | Syringes and syringe systems for selectively dispensing controlled amounts of a therapeutic substance |
FR2922112B1 (fr) * | 2007-10-11 | 2009-12-04 | Rexam Pharma La Verpilliere | Dispositif de securite pour une seringue d'injection de liquide et ensemble a seringue comprenant ce dispositif |
US9186464B2 (en) * | 2008-05-15 | 2015-11-17 | Allergan, Inc. | Dosing injector |
EP2682145B1 (en) * | 2011-03-01 | 2020-11-25 | Terumo Kabushiki Kaisha | Syringe and syringe assembly |
EP2762185A4 (en) | 2011-09-26 | 2015-05-13 | Terumo Corp | LIQUID INJECTION INSTRUMENT |
JP5855522B2 (ja) * | 2012-04-27 | 2016-02-09 | 株式会社吉野工業所 | 定量シリンジ型噴出器 |
JPWO2015151692A1 (ja) * | 2014-03-31 | 2017-04-13 | テルモ株式会社 | シリンジ |
-
2015
- 2015-03-03 WO PCT/JP2015/056188 patent/WO2015151693A1/ja active Application Filing
- 2015-03-03 EP EP15774457.4A patent/EP3127572B1/en active Active
- 2015-03-03 JP JP2016511476A patent/JP6499158B2/ja active Active
-
2016
- 2016-09-29 US US15/280,637 patent/US10625025B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080132852A1 (en) * | 2004-07-28 | 2008-06-05 | Kleyhan Gennady I | Dosage device |
JP2007159717A (ja) * | 2005-12-12 | 2007-06-28 | Maeda Sangyo Kk | 注射器 |
JP2008073519A (ja) * | 2006-08-25 | 2008-04-03 | Dainippon Sumitomo Pharma Co Ltd | 注射器及びプランジャロッド |
JP2012139330A (ja) * | 2010-12-28 | 2012-07-26 | Yoshino Kogyosho Co Ltd | シリンジ容器 |
WO2014045405A1 (ja) * | 2012-09-21 | 2014-03-27 | テルモ株式会社 | 薬剤投与器具 |
Non-Patent Citations (1)
Title |
---|
See also references of EP3127572A4 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018037034A1 (en) * | 2016-08-26 | 2018-03-01 | Sanofi-Aventis Deutschland Gmbh | Audible indicator |
WO2018037030A1 (en) * | 2016-08-26 | 2018-03-01 | Sanofi-Aventis Deutschland Gmbh | Audible indicator |
CN109641110A (zh) * | 2016-08-26 | 2019-04-16 | 赛诺菲-安万特德国有限公司 | 听觉指示器 |
CN109641109A (zh) * | 2016-08-26 | 2019-04-16 | 赛诺菲-安万特德国有限公司 | 听觉指示器 |
JP2019524375A (ja) * | 2016-08-26 | 2019-09-05 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 可聴インジケータ |
JP2019528129A (ja) * | 2016-08-26 | 2019-10-10 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 可聴インジケータ |
CN109641109B (zh) * | 2016-08-26 | 2022-06-03 | 赛诺菲-安万特德国有限公司 | 听觉指示器 |
US11369744B2 (en) | 2016-08-26 | 2022-06-28 | Sanofi-Aventis Deutschland Gmbh | Audible indicator |
JP7142628B2 (ja) | 2016-08-26 | 2022-09-27 | サノフィ-アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 可聴インジケータ |
JP7257319B2 (ja) | 2016-08-26 | 2023-04-13 | サノフィ-アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 可聴インジケータ |
US11771838B2 (en) | 2016-08-26 | 2023-10-03 | Sanofi-Aventis Deutschland Gmbh | Audible indicator |
Also Published As
Publication number | Publication date |
---|---|
JPWO2015151693A1 (ja) | 2017-04-13 |
EP3127572A4 (en) | 2017-12-20 |
US10625025B2 (en) | 2020-04-21 |
EP3127572A1 (en) | 2017-02-08 |
JP6499158B2 (ja) | 2019-04-10 |
US20170014574A1 (en) | 2017-01-19 |
EP3127572B1 (en) | 2021-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6499158B2 (ja) | プレフィルドシリンジ | |
JP6284595B2 (ja) | 注射針組立体及び薬剤注射装置 | |
JP6738937B2 (ja) | シリンジ | |
US8162883B2 (en) | Puncture needle assembly and medicinal liquid injector | |
US10238817B2 (en) | Prefilled syringe | |
JP6752775B2 (ja) | シリンジホルダ及び薬液投与セット | |
JP2013517919A (ja) | 医療用針安全装置 | |
WO2015001819A1 (ja) | 液体投与具 | |
WO2011125560A1 (ja) | プレフィルドシリンジ | |
WO2014122782A1 (ja) | プレフィルドシリンジ | |
JPWO2011122393A1 (ja) | プレフィルドシリンジ | |
WO2013046857A1 (ja) | プロテクタおよびシリンジ組立体 | |
JP6914913B2 (ja) | 薬液投与器具、薬液投与器具の使用方法及び薬液投与器具の製造方法 | |
WO2014162439A1 (ja) | シリンジ | |
WO2011068131A1 (ja) | プレフィルドシリンジ | |
WO2016158144A1 (ja) | 薬剤注射装置 | |
JP6360470B2 (ja) | 液体投与具 | |
JP2011115345A (ja) | プレフィルドシリンジ | |
JP2012029723A (ja) | 注射針組立体、及び薬剤注射装置 | |
JP2013188431A (ja) | シリンジ | |
JP2011212184A (ja) | プレフィルドシリンジ | |
EP4190377A1 (en) | Pre-filled syringe | |
WO2017170638A1 (ja) | シリンジ | |
KR20180112982A (ko) | 재사용이 불가능한 스마트 주사기(2) | |
JP2002078801A (ja) | 液体注入器具 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15774457 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2016511476 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2015774457 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015774457 Country of ref document: EP |